Buckcanan VA, Alvarado AM, Monge OOP, Guzmán CR, Leitón MI, Sedó MG

Language: Spanish
References: 20
Page: 1-7
PDF size: 748.78 Kb.

ABSTRACT

We present the case of a 13-year-old patient with a rapidly progressive systemic lupus erythematosus without antineutrophil antibodies, associated with infection by Epstein-Barr virus and antiphospholipid syndrome.
A therapeutic and diagnostic approach was made according to the complications suffered; as a bronchopneumonia, upper digestive bleeding, and renal failure, which in that sense led to multiorgan failure and consequently to his death.
is report centers on the most relevant clinical findings focusing on the association between the various conditions that entail a well-known disease with an atypical presentation.

REFERENCES

1. Weening J J. The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited. Kidney Int. 2004; 65: 521-530.

2. Lawrence R Helmick G Arnett C et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis & Rheum. 1998; 41: 778-799

3. Pons-Estel G Alarcón G Scofield L Reinlib L Cooper G. Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus. Semin Arthritis Rheum. 2010; 39: 257.

4. Tsokos G. Systemic Lupus Erythematosus. N Engl J Med. 2011; 365: 2110-2121

5. Costenbader K Feskanich D Stampfer M Karlson E. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum. 2007; 56: 1251-1262.

6. Lahita R. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol. 1999; 11: 352-356.

7. Petri M Orbai A Alarcón G Gordon C Merrill J Fortin P Magder L. Derivation and Validation of Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheum. 2012; 64: 2677– 2686.

8. Cross L Aslam A Misbah S. Antinuclear antibody-negative lupus as a distinct diagnostic entity— does it no longer exist? QJM. 2004; 97: 303-308.

9. Freire J Correia M Vendramini M Bonfá E. Clinical and laboratory evaluation of patients with primary antiphospholipid syndrome according to the frequency of antinuclear antibodies (ANA Hep- 2). Brazilian Journal of Rheumatology. 2010; 50: 262- 272.

10. Zafrir Y Gilburd B Carrasco M Kivity S Sánchez M López M Agmon N. Evaluation of an automated chemiluminescent immunoassay kit for antinuclear antibodies in autoimmune diseases. Immunol Res, 2013; 56: 451-456.

11. Ghillani P Rouquette A Desgruelles C Hauguel N Pendeven C Piette J Musset L. Evaluation of the LIAISON ANA Screen Assay for Antinuclear Antibody Testing in Autoimmune Diseases. Ann N Y Acad Sci, 2007;1109: 407-413.

12. Ulff-Møller C Nielsen N Rostgaard K Hjalgrim H Frisch M. Epstein–Barr virus-associated infectious mononucleosis and risk of systemic lupus erythematosus. Baillieres Clin Rheumatol. 2010; 49: 1706-1712.

13. Draborg A Duus K Houen G. Epstein-Barr Virus and Systemic Lupus Erythematosus. Journal of Immunology Research. 2012; 2012: 10.

14. Larsen S. Syphilis. Clin Lab Med. 1989; 9: 545.

15. Simmons S Smith M Chang A Keddis M. Antinuclear Antibody-Negative Lupus Nephritis with Full House Nephropathy: A Case Report and Review of the Literature. Am J Nephrol. 2015; 42: 451-459.

16. Jennette J Olson J Silva F DAgati V. Heptinstalls pathology of the kidney. 2015; 7ed: 573-579

17. Jennette J Iskandar S Dalldorf F. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int, 1983; 24: 377-385.

18. McCoy R. Nuclear Localization of Immunoglobulins in Renal Biopsies of Patients with Lupus Nephritis. Am J Pathol. 1972; 68: 469–478.

19. Williams D Peters D Fallows J Petrie A Kourilsky O Morel L Cameron J. Studies of serum complement in the hypocomplementaemic nephritides. Clin Exp Immunol.1974; 18: 391–405.

20. Appel G Pirani C D’Agati V. Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol. 1994; 4:1499-1515.